The Associated Press on MSN5d
EU Commission fines Teva $500 million for trying to stop rival’s multiple sclerosis drugThe European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...
Teva Pharmaceuticals is being fined $503 million (€463 million) by the European Commission for delaying competition posed by ...
GlobalData on MSN4d
EC fines Teva $502m over multiple sclerosis treatment Copaxone practicesThe European Commission (EC) has imposed a fine of €462.6m ($502m) on Teva Pharmaceuticals Industries after investigating the ...
European Commission says company abused ‘dominant position’ to ‘artificially’ extend patent protection of MS medicine ...
The fine of €462.6 million ($503 million) is believed to be the largest imposed on a pharma company for breaking antitrust ...
The European Commission (EC) has fined pharmaceutical company Teva €462.6 million for “systematically spread[ing] misleading ...
Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns ...
Teva Statement on European Commission Decision; Company to Appeal GlobeNewswire October 31, 2024 Teva Pharmaceuticals ...
BRUSSELS -- The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its ...
TEL AVIV, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals Industries Ltd. (NYSE: and TASE: TEVA) is responding to the European ... disagrees with the Commission’s legal theories ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback